Delineation of atypical insulin receptors from classical insulin and type I insulin-like growth factor receptors in human placenta
- 1 January 1989
- journal article
- research article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 257 (1), 101-107
- https://doi.org/10.1042/bj2570101
Abstract
Insulin-like growth factor (IGF)-binding sites copurifying with human placental insulin receptors during insulin-affinity chromatography consist of two immunologically distinct populations. One reacts with monoclonal antibody alpha IR-3, but not with antibodies to the insulin receptor, and represents Type I IGF receptors; the other reacts only with antibodies to the insulin receptor and is precipitated with a polyclonal receptor antibody (B-10) after labelling with 125I-multiplication-stimulating activity (MSA, rat IGF-II). The latter is a unique sub-population of atypical insulin receptors which differ from classical insulin receptors by their unusually high affinity for MSA (Ka = 2 x 10(9) M-1 compared with 5 x 10(7) M-1) and relative potencies for insulin, MSA and IGF-I (40:5:1 compared with 150:4:1). They represent 10-20% of the total insulin receptor population and account for 25-50% of the 125I-MSA binding activity in Triton-solubilized placental membranes. Although atypical and classical insulin receptors are distinct, their immunological properties are very similar, as are their binding properties in response to dithiothreitol, storage at -20 degrees C and neuraminidase digestion. We conclude that atypical insulin receptors with moderately high affinity for IGFs co-exist with classical insulin receptors and Type I IGF receptors in human placenta. They provide an explanation for the unusual IGF-II binding properties of human placental membranes and may have a specific role in placental growth and/or function.This publication has 26 references indexed in Scilit:
- Separation of the high affinity insulin-like growth factor I receptor from low affinity binding sites by affinity chromatography.Journal of Biological Chemistry, 1987
- Monensin blocks the maturation of receptors for insulin and somatomedin C: Identification of receptor precursorsProceedings of the National Academy of Sciences, 1983
- Monoclonal antibodies to the human insulin receptor block insulin binding and inhibit insulin action.Proceedings of the National Academy of Sciences, 1982
- Insulin Resistance Associated with Androgen Excess in Women with Autoantibodies to the Insulin ReceptorAnnals of Internal Medicine, 1982
- Structural differences between insulin and somatomedin-C/insulin-like growth factor-1 receptors revealed by autoantibodies to the insulin receptorBiochemical and Biophysical Research Communications, 1982
- Purification of tracer for somatomedin C radioimmunoassay by hydrophobic interaction chromatography.Clinical Chemistry, 1982
- A Preferential Binding Site for Insulin-Like Growth Factor II in Human andRat Placental Membranes*Journal of Clinical Endocrinology & Metabolism, 1981
- Purification and primary structure of a polypeptide with multiplication-stimulating activity from rat liver cell cultures. Homology with human insulin-like growth factor II.Journal of Biological Chemistry, 1981
- Purification of somatomedin-C from human plasma: chemical and biological properties, partial sequence analysis, and relationship to other somatomedinsBiochemistry, 1980
- [16] Methods for assessing immunologic and biologic properties of iodinated peptide hormonesMethods in Enzymology, 1975